Detection of platelet adhesion/aggregation to immobilized ligands on microbeads by an aggregometer

Thrombosis and Haemostasis

Volumn 76, Issue 6, 1996, Pages 1072-1079

  Minamoto, Yoko ^a   Hato, Takaaki ^a   Nakatani, Shingo ^a   Fujita, Shigeru ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; LIGAND; PLECKSTRIN; PROTEIN KINASE C INHIBITOR; SCAVENGER; THROMBOXANE B2; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMMOBILIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TURBIDIMETRY;

EID: 0030473089     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650708     Document Type: Article

References (46)

1. Sixma JJ, de Groot PG. Regulation of platelet adhesion to the vessel wall. Ann NY Acad Sci 1994; 714: 190-9.
2. Ruggeri ZM. Glycoprotein Ib and von Willebrand factor in the process of thrombus formation. Ann NY Acad Sci 1994; 714: 200-10.
3. Sakariassen KS, Bolhuis PA, Sixma JJ. Adhesion of human blood platelets to human artery subendothelium is mediated by factor VIII-von Willebrand factor bound to subendothelium. Nature 1979; 279: 636-8.
4. Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986; 67: 322-30.
5. Sakariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-91.
6. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-6.
7. Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-43.
8. Lawrence JB, Gralnick HR. Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: Effects on platelet spreading and ultrastructure on human arterial subendothelium. J Lab Clin Med 1987; 109: 495-503.
9. Olson JD, Zaleski A, Herrmann D, Flood PA. Adhesion of platelets to purified solid-phase von Willebrand factor: Effects of wall shear rate, ADP, thrombin, and ristocetin. J Lab Clin Med 1989; 14: 6-18.
10. Weiss HJ, Turitto VT, Baumgartner HR. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost 1991; 65: 202-5.
11. 1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. J Lab Clin Med 1993; 122: 324-32.
12. Coller BS. Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interaction in thrombasthenia. Blood 1980; 55: 169-78.
13. Savage B, Ruggeri M. Selective recognition of adhesive sites in surfacebound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227-33.
14. 3. Thromb Haemost 1993; 70: 224-8.
15. Olson JD, Moake JL, Collins MF, Michael BS. Adhesion of human platelets to purified solid-phase von Willebrand factor: Studies of normal and Bernard-Soulier platelets. Thromb Res 1983; 32: 115-22.
16. Lankhof H, Wu Y-P, Vink T, Schiphorst ME, Zerwes H-G, de Groot PG, Sixma JJ. Role of the glycoprotein Ib-binding Al repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood 1995; 86: 1035-42.
17. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol (London ) 1962; 162: 67P-8P.
18. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973; 5: 167-79.
19. Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
20. Hubble JA, McIntire LV. Technique for visualization and analysis of mural thrombogenesis. Rev Sci Instrum 1986; 57: 892-7.
21. Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: Deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med 1987; 110: 706-18.
22. Poot A, Beugeling T, Cazenave JP, Bantjes A, van Aken WG. Platelet deposition in a capillary perfusion model: quantitative and morphological aspects. Biomaterials 1988; 9: 126-32.
23. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
24. Hato T. The role of glycoprotein IIb-IIIa complex in ristocetin-stimulated platelets as revealed by a monoclonal antibody. Acta Haematol Jpn 1987; 50: 129-37.
25. vwf by a combined albumin gradient-gel filtration method using Hepes buffer. Thromb Res 1978; 12: 297-306.
26. Watanabe A, Hato T, Kobayashi Y. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4. Int J Hematol 1992; 56: 79-87.
27. Pfueller SL, Firkin BG. Role of plasma proteins in the interaction of human platelets with particles. Thromb Res 1978; 12: 979-90.
28. Baumgartner HR, Muggli R, Tschopp TB, Turitto VT. Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties and platelet function. Thromb Haemost 1976; 35: 124-38.
29. Danton MC, Zaleski A, Nichols WL, Olson JD. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. J Lab Clin Med 1994; 124: 274-82.
30. Jen CJ, Lin JS. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces. Am J Physiol 1991; 30: H1457-63.
31. Shattil SJ, Brass LF. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 992-1000.
32. Shattil SJ, Cunningham M, Wiedmer T, Zhao J, Sims PJ, Brass LF. Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. J Biol Chem 1992; 267: 18424-31.
33. Loh E, Beaverson K, Vilaire G, Qi W, Poncz M, Bennett JS. Agonist-stimulated ligand binding by the platelet integrin αIIbβ3 in a lymphocyte expression system. J Biol Chem 1995; 270: 18631-6.
34. Gabbela J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood 1996; 87: 1368-76.
35. Furman MI, Grigoryev D, Bray PF, Dise KR, Goldschmidt-Clermont PJ. Platelet tyrosine kinases and fibrinogen receptor activation. Circ Res 1994; 75: 172-80.
36. 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers. J Biol Chem 1994; 269: 32479-87.
37. Oda A, Yokoyama K, Murata M, Tokuhira M, Nakamura K, Handa M, Watanabe K. Ikeda Y. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GPIIb/IIIa and requires intact cytoskeleton and endogenous ADP. Thromb Haemost 1995; 74: 736-42.
38. Parker RI, Gralnick HR. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets. Blood 1989; 74: 2016-21.
39. Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor: An important determinant of the bleeding time in type I von Willebrand's disease. Blood 1986; 68: 58-61.
40. Fressinaud E, Federici AB, Castaman G, Rothschild C, Rodeghiero F, Baumgartner HR, Mannucci PM, Meyer D. The role of platelet von Willebrand factor in platelet adhesion and thrombus formation; A study of 34 patients with various subtypes of type I von Willebrand disease. Br J Haematol 1994; 86: 327-32.
41. Beumer S, Heijnen HFG, IJsseldijk MJW, Orlando E, de Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: The importance of von Willebrand factor and glycoprotein Ib. Blood 1995; 86: 3452-60.
42. 3, (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 1991; 88: 1128-34.
43. Lambrecht LK, Young BR, Stafford RE, Park K, Albrecht RM, Mosher DF, Cooper SL. The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosis. Thromb Res 1986; 41: 99-117.
44. Haimovich B, Lipfert L, Brugge JS, Shattil SJ, Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 1993; 268: 15868-77.
45. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
46. Greco NJ, Tandon NN, Jackson B, Jamieson GA. Adenine nucleotide binding and photoincorporation in Glanzmann's thrombasthenia platelets. Biochim Biophys Acta 1995; 1236: 142-8.